MRMD

MariMed Inc. [MRMD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MRMD Stock Summary

Top 10 Correlated ETFs

MRMD


Top 10 Correlated Stocks

MRMD


In the News

07:35 29 Mar 2024 MRMD

The 7 Most Undervalued Cannabis Stocks to Buy in December

Given that cannabis legalization is considered a growth trend, you may assume that there are few (if any) undervalued cannabis stocks. However, whether we're talking about undervalued in the traditional sense of the term, or undervalued using other metrics, there are plenty of names in the space that fit within this category.

12:33 29 Mar 2024 MRMD

Top Marijuana Stocks For The 2024 Green Rush

Marijuana stocks are still in a volatile place in the stock market. Yet this has played a part in why they can invest in the future of cannabis at low price points. Right now there is a lack of upward trading consistency for the sector. Meaning that most cannabis stocks can not sustain an upward position in the market. Often when there is a volatile rise in trading it is short-lived only seeing a recovery for just a few minutes even just moments.

07:30 29 Mar 2024 MRMD

Top 3 Marijuana Penny Stocks to Watch Post-Thanksgiving

The United States cannabis industry and top marijuana stocks are witnessing a remarkable expansion. Recent forecasts predict significant growth in the coming years. This surge is fueled by increasing legalization and societal acceptance. As a result, investors are keenly observing marijuana penny stocks. These stocks represent companies in the developing phase of the cannabis sector. They offer unique growth opportunities. However, their low share prices often reflect higher volatility and risk.

10:00 29 Mar 2024 MRMD

Reasons To Be Cautiously Optimistic About Cannabis

Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.

05:15 29 Mar 2024 MRMD

MariMed to Participate in Upcoming Investor Conferences

NORWOOD, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced its participation in the following upcoming investor conferences:

07:30 29 Mar 2024 MRMD

Top Marijuana Penny Stocks for September 2023

Welcome to the worldwide arena of marijuana stocks in the ever-changing cannabis sector, where the intersection of financial prospects and rising legality is creating a buzz unlike any other. As we approach September 2023, the stage is set for investors to investigate the top marijuana penny stocks with enormous growth potential. Technical analysis is critical in both day trading and swing trading methods in this volatile market, providing traders with vital insights into price movements and trends.

09:42 29 Mar 2024 MRMD

7 Smoking-Hot 420 Stocks to Buy in 2023

Sentiment for the cannabis sector has yet to rebound from its last peak in late 2020/early 2021, but that doesn't mean you need to skip out on 420 stocks. Even Forbes recently argued that full U.S. legalization of marijuana remains (at least) a decade away.

02:00 29 Mar 2024 MRMD

Green Earnings: Cannabis Penny Stocks with Potential Amidst Reporting Season

August 2023 is a good time for individuals interested in the volatile world of marijuana stocks. Because of the growing legality and acceptability of cannabis products, these emerging companies, frequently distinguished by low stock prices, have attracted considerable interest. As investors look for new opportunities, it's critical to identify the top marijuana penny stocks primed for growth in this turbulent but potentially lucrative industry. With creative developments, evolving regulatory landscapes, and shifting customer preferences impacting the sector, discerning investors are directing their attention to companies that demonstrate excellent fundamentals and a strategic understanding of market trends.

07:30 29 Mar 2024 MRMD

Top Marijuana Penny Stocks to Watch in August 2023

Welcome to the intriguing world of marijuana penny stocks! As we approach August 2023, the cannabis sector is witnessing rapid growth and drawing investors looking to cash in on the green revolution. Penny stock trading can be exciting and risky; therefore, it is critical to approach these investments with caution and sound risk management measures.

12:00 29 Mar 2024 MRMD

Unlocking Short-Term Gains: Top Marijuana Stocks Before August 2023

As we approach the midway point of 2023, the cannabis industry continues to garner attention from investors seeking lucrative opportunities. With increasing legalization efforts across the United States and beyond, marijuana stocks are poised for potential growth and profitability.

MRMD Financial details

Company Rating
Buy
Market Cap
105.79M
Income
-16.05M
Revenue
148.6M
Book val./share
0.19
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
643
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-94.1
Forward P/E
27.25
PEG
4.55
P/S
0.74
P/B
1.3
P/C
6.81
P/FCF
-9.41
Quick Ratio
0.58
Current Ratio
1.44
Debt / Equity
1.24
LT Debt / Equity
1.21
-
-
EPS (TTM)
-0.04
EPS next Y
0.01
EPS next Q
-0.01
EPS this Y
-209.43%
EPS next Y
-111.63%
EPS next 5Y
-169.77%
EPS last 5Y
-32.72%
Revenue last 5Y
26.65%
Revenue Q/Q
0.26%
EPS Q/Q
136.84%
-
-
-
-
SMA20
-3.57%
SMA50
-10%
SMA100
-18.18%
Inst Own
0.18%
Inst Trans
0.75%
ROA
-1%
ROE
-2%
ROC
0.1%
Gross Margin
44%
Oper. Margin
11%
Profit Margin
-1%
Payout
-14%
Shs Outstand
375.13M
Shs Float
313.44M
-
-
-
-
Target Price
2.25
52W Range
0.203-0.545
52W High
-
52W Low
-
RSI
51.83
Rel Volume
1.1
Avg Volume
498.24K
Volume
549.09K
Perf Week
-0.91%
Perf Month
-7.63%
Perf Quarter
-33.7%
Perf Half Y
-40.37%
-
-
-
-
Beta
2.851
-
-
Volatility
0.01%, 0.02%
Prev Close
4.57%
Price
0.2725
Change
2.64%

MRMD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.220.160.340.350.41
Net income per share
-0.320.010.020.04-0.04
Operating cash flow per share
-0.120.010.10.020.02
Free cash flow per share
-0.1600.05-0.01-0.04
Cash per share
0.010.010.080.030.04
Book value per share
0.030.030.10.150.2
Tangible book value per share
0.010.010.090.090.11
Share holders equity per share
0.030.030.10.150.2
Interest debt per share
0.270.160.070.10.27
Market cap
128.61M152.36M312.48M135.44M99.86M
Enterprise value
170.58M191.97M307.16M161.56M184.34M
P/E ratio
-1.9371.0643.2510.06-6.23
Price to sales ratio
2.822.992.571.010.67
POCF ratio
-5.3345.078.7218.5312.62
PFCF ratio
-3.77-97.5118.07-24.94-7.77
P/B Ratio
18.6917.568.252.31.4
PTB ratio
18.6917.568.252.31.4
EV to sales
3.743.772.531.211.24
Enterprise value over EBITDA
-8.4810.759.625.287.79
EV to operating cash flow
-7.0756.798.5722.123.31
EV to free cash flow
-5-122.8617.77-29.75-14.35
Earnings yield
-0.520.010.020.1-0.16
Free cash flow yield
-0.27-0.010.06-0.04-0.13
Debt to equity
6.214.910.640.611.24
Debt to assets
0.690.560.20.240.45
Net debt to EBITDA
-2.092.22-0.170.853.57
Current ratio
0.20.911.641.671.67
Interest coverage
0.441.4811.412.031.64
Income quality
0.291.394.70.54-0.49
Dividend Yield
00000
Payout ratio
-0.010.140.060.02-0.01
Sales general and administrative to revenue
0.280.30.30.260.3
Research and developement to revenue
00000
Intangibles to total assets
0.040.030.020.150.15
Capex to operating cash flow
0.41-1.46-0.52-1.74-2.62
Capex to revenue
-0.22-0.1-0.15-0.1-0.14
Capex to depreciation
-8.34-2.27-6.66-2.7-2.42
Stock based compensation to revenue
00.020.10.050.01
Graham number
0.490.060.220.350.44
ROIC
0.080.140.130.140.21
Return on tangible assets
-1.120.030.060.1-0.1
Graham Net
-0.24-0.17-0.14-0.18-0.25
Working capital
-29.34M-2.18M17.39M17.66M20.57M
Tangible asset value
3.96M5.87M34.07M35.03M40.91M
Net current asset value
-47.87M-47.3M-42.29M-50.75M-74.78M
Invested capital
6.214.910.640.611.24
Average receivables
7.58M6.53M6.37M5.5M8.26M
Average payables
4.32M4.88M5.07M5.86M7.81M
Average inventory
609.71K4.03M8.3M14.62M22.39M
Days sales outstanding
30.2366.5110.4320.522.07
Days payables outstanding
64.0394.0933.7134.5231.2
Days of inventory on hand
16.54127.464.59101.4887.73
Receivables turnover
12.075.493517.816.54
Payables turnover
5.73.8810.8310.5711.7
Inventory turnover
22.062.875.653.64.16
ROE
-9.670.250.190.23-0.22
Capex per share
-0.05-0.02-0.05-0.03-0.06

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.090.10.10.10.1
Net income per share
0.0100-0.01-0.03
Operating cash flow per share
0-0.0100.020.01
Free cash flow per share
0-0.02-0.010.01-0.01
Cash per share
0.030.060.040.040.04
Book value per share
0.150.190.230.220.19
Tangible book value per share
0.090.10.140.130.11
Share holders equity per share
0.150.190.230.220.19
Interest debt per share
0.10.20.190.180.24
Market cap
136M134.55M148.12M162.5M103.33M
Enterprise value
162.12M177.93M198.95M213.24M187.81M
P/E ratio
7.16-50.66-38.65-9.54-2.54
Price to sales ratio
3.83.914.064.192.66
POCF ratio
78.3-29.91116.1720.5731.95
PFCF ratio
-197.39-16.5-33.2284.99-48.13
P/B Ratio
2.312.011.81.991.44
PTB ratio
2.312.011.81.991.44
EV to sales
4.525.185.455.54.83
Enterprise value over EBITDA
23.3639.7248.3482.4937.46
EV to operating cash flow
93.33-39.55156.0426.9958.07
EV to free cash flow
-235.3-21.83-44.62111.53-87.47
Earnings yield
0.030-0.01-0.03-0.1
Free cash flow yield
-0.01-0.06-0.030.01-0.02
Debt to equity
0.610.970.790.791.24
Debt to assets
0.240.350.350.340.45
Net debt to EBITDA
3.769.6812.3519.6316.85
Current ratio
1.672.421.981.441.67
Interest coverage
13.151.171.341.331.58
Income quality
0.376.78-1.36-1.85-0.32
Dividend Yield
00000
Payout ratio
0.01-0.05-0.05-0.010
Sales general and administrative to revenue
0.230.260.290.310.34
Research and developement to revenue
00000
Intangibles to total assets
0.150.170.160.160.15
Capex to operating cash flow
-1.40.81-4.5-0.76-1.66
Capex to revenue
-0.07-0.11-0.16-0.15-0.14
Capex to depreciation
-1.74-2.37-2.81-2.46-2.11
Stock based compensation to revenue
00.010.010.010.01
Graham number
0.210.090.120.240.34
ROIC
0.09-0.01-0.02-0.460.02
Return on tangible assets
0.040-0.01-0.03-0.06
Graham Net
-0.18-0.23-0.21-0.21-0.24
Working capital
17.66M34.87M28.69M15.5M20.57M
Tangible asset value
35.03M33.79M50.21M50.01M40.91M
Net current asset value
-50.75M-59.75M-50.55M-60.16M-74.78M
Invested capital
0.610.970.790.791.24
Average receivables
7.47M7.62M8.28M8M8.06M
Average payables
7.3M5.65M6.21M8.13M8.75M
Average inventory
18.89M21.1M23.75M24.5M24.76M
Days sales outstanding
18.9120.1821.8216.5620.79
Days payables outstanding
29.7922.1134.6934.8128.93
Days of inventory on hand
87.57107.68110.7599.281.33
Receivables turnover
4.764.464.135.434.33
Payables turnover
3.024.072.592.593.11
Inventory turnover
1.030.840.810.911.11
ROE
0.08-0.01-0.01-0.05-0.14
Capex per share
-0.01-0.01-0.02-0.02-0.01

MRMD Frequently Asked Questions

What is MariMed Inc. stock symbol ?

MariMed Inc. is a US stock , located in Norwood of Ma and trading under the symbol MRMD

Is MariMed Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $2.25. The lowest prediction is $2.25 and the highest is $2.25

What is MRMD stock prediction ?

What is MariMed Inc. stock quote today ?

MariMed Inc. stock price is $0.2725 today.

Is MariMed Inc. stock public?

Yes, MariMed Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap